Jan 15, 2019
On the basis of therapeutic application, the market is segmented into oncology, cardiology, psychiatry, infectious diseases, pain management, neurological disorders and others. Among these, oncology segment dominates the therapeutic market followed by psychiatry and infectious diseases.

Pune, India - January 15, 2019 /MarketersMedia/ —
Rising demand for various techniques to pinpointing diagnoses down to the subtype of chronic conditions will drive the pharmacogenomics market. Increasing prevalence of several infectious and non-infectious diseases is also one of the major factors boosting the demand for regulated next-generation sequencing-based clinical trial assays and companion diagnostics.
For Sample Copy of this Report Visit @ https://www.orianresearch.com/request-sample/722400
The Global Pharmacogenomics Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. Increasing prevalence of several infectious and non-infectious diseases, rising usage in drug discovery processes are the major factors driving the Pharmacogenomics market. Lack of awareness and lack of consistency in pharmacogenomics products will restrain the market growth during the forecast period.
The screening of known polymorphic drug metabolism enzymes and transporters (DMET) is rapidly becoming routine practice in clinical research. So manufacturers are currently focusing on various approaches to pharmacogenomics analysis to provide rapid and cost-effective solutions for both the screening of known polymorphisms and discovery of novel variants.
On the basis of technology, the market is segmented into microarray, sequencing, polymerase chain reaction, and others. Sequencing dominates the market, especially with the advent of next generation sequencing attributed by high throughput screening, high accuracy and speed.
North America held the largest and the fastest market owing to presence of major key players and strategic collaborations among them. Asia Pacific is also expected to exhibit substantial growth rate after North America due to increased investments in R&D and increasing number of clinical trials.
Some of the key players operating in this market include Affymetrix, Inc., AstraZeneca plc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Bayer AG, Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Myriad Genetics, Inc., and Pathway Genomics Corporation.
Global Pharmacogenomics Industry is spread across 121 pages, profiling 10 companies and supported with tables and figures.
Inquire more or share a question if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/722400 .
Key Benefits of the Report:
* Global, Regional, Country, Insight Type, and Application Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTEL, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Insight Type & Application, and competitive landscape with qualitative and quantitative information and facts
Target Audience:
* Pharmacogenomics providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies
Order a copy of Global Pharmacogenomics Market Report 2018 @ https://www.orianresearch.com/checkout/722400 .
Research Methodology
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.
For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.
The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Equipment Manufacturer,
* Application Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute
TABLE OF CONTENT
1 Executive Summary
2 Methodology And Market Scope
3 Pharmacogenomics Market — Industry Outlook
4 Pharmacogenomics Market Technology Outlook
5 Pharmacogenomics Market Therapeutic Application Outlook
6 Pharmacogenomics Market Regional Outlook
7 Competitive Landscape
End of the report
Disclaimer
About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.
Contact Info:
Name: Ruwin Mendez
Email: Send Email
Organization: Orian Research
Website: https://www.orianresearch.com/report/pharmacogenomics/722400
Source: MarketersMedia
Release ID: 470877
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
Jack Martin-Harley, 33, used his privileged access at £37,000-a-year d'Overbroeck's in Oxford to help himself to pupils' cash, jewellery and electronic goods in a four-month spree.
The charity, Choose Love, will receive half of actor Croft's £83,000 prize, despite claiming on its website that Palestinians 'are still experiencing a genocide'
The Tory leader issued a sharp rebuke to the Prime Minister's suggestion he could apologise for Britain's role in the slave trade.
As trustees of Liberty Recycling, Linda Behan, her husband Brian Behan - together with Sinn Féin TD, Aengus Ó Snodaigh -- are legally responsible for the governance of the charity.
The US President has approved the sale of 500 vital mobile interceptor surface-to-air missile systems after Volodymyr Zelenskyy pleaded with Western leaders to speed up deliveries.
Hollywood idol James McAvoy has been branded 'absurd' after blaming England for Scots hitting the bottle.
The Energy Secretary was looking increasingly isolated in Cabinet last night as Labour sources indicated the Government was breaking with Net Zero ideology.
More accustomed to a life of private jets and mansions, the three brothers now wait to see which federal prison they are sent to after they were each sentenced to 30 years.
A chilling video recording from inside the store showed witnesses ducking for cover as gunshots rang out.
U2 this week announced the first shows of an upcoming world tour, which will start in Mexico in February and is set to conclude in Dublin, possibly in 2028.
The revelation comes after Scotland Yard confirmed it handed the Duchess of Sussex, 45, a letter containing allegations against Thomas Markle, 82, in January 2019.
The Prime Minister's comments immediately triggered calls from leaders in the West Indies for Britain to pay billions of pounds in reparations.